REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09995 REMEGEN

Trading 10-15 14:41:40

64.250

-2.400

-3.60%

High67.050	Low63.300	Vol2.52M
Open66.000	D1 Closing66.650	Amplitude5.63%
Mkt Cap36.21B	Tradable Cap13.40B	Total Shares563.61M
T/O163.57M	T/O Rate1.21%	Tradable Shares208.58M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"REMEGEN","latestPrice":64.25,"timestamp":1792046497360,"preClose":66.65,"halted":0,"volume":2515000,"delay":0,"changeRate":-0.03600900225056272,"floatShares":208581239,"shares":563608243,"eps":1.5126110226086684,"marketStatus":"Trading","change":-2.4,"latestTime":"10-15 14:41:40","open":66,"high":67.05,"low":63.3,"amount":163566610,"amplitude":0.056264,"askPrice":64.3,"askSize":5000,"bidPrice":64.2,"bidSize":13000,"shortable":3,"etf":0,"ttmEps":12.178786475967009,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1792051800000},"marketStatusCode":2,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":66.65,"openAndCloseTimeList":[[1792027800000,1792036800000],[1792040400000,1792051200000]],"volumeRatio":1.817129,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"Remegen Co.,Ltd.","latestPrice":99.27,"timestamp":1792046493000,"preClose":101.45,"halted":0,"volume":4371500,"delay":0,"premium":"-44.80"}},"requestUrl":"/m/hq/s/09995/tweets","defaultTab":"tweets","newsList":[{"id":"1129997446","title":"Movement Alert｜REMEGEN falls 5.03% in Regular Trading, after disclosing RMB370 million purchase of SPD Bank wealth products","url":"https://stock-news.laohu8.com/highlight/detail?id=1129997446","media":"Market Focus","labels":[],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1129997446?lang=en_us&edition=fundamental","pubTime":"2026-10-15 13:26","pubTimestamp":1792041982,"startTime":"0","endTime":"0","summary":"On October 15, REMEGEN fell 5.03% in regular trading, trading at HK$63.35, with turnover of HK$133 million.The latest disclosed catalyst is the company’s announcement that it signed two wealth...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"REMEGEN drops on RMB370M wealth product purchase disclosure","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197329512","title":"RemeGen Acquires Additional RMB370.00 Million Principal-Guaranteed Wealth Products from SPDB, Raising 12-Month Total to RMB670.00 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1197329512","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197329512?lang=en_us&edition=fundamental","pubTime":"2026-10-14 17:41","pubTimestamp":1791970892,"startTime":"0","endTime":"0","summary":"RemeGen Co., Ltd. (RemeGen) disclosed that on 14 October 2026 it entered into two new wealth-management agreements with Shanghai Pudong Development Bank’s Yantai Branch (SPDB Yantai). The company...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148490496","title":"HK Movers | Biotech Stocks Fall Broadly; AKESO Down Over 10%, ZAI LAB Down Over 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148490496","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148490496?lang=en_us&edition=fundamental","pubTime":"2026-10-14 09:49","pubTimestamp":1791942575,"startTime":"0","endTime":"0","summary":"On Wednesday, Hong Kong-listed biotech and pharmaceutical stocks fell broadly. $AKESO(09926)$ dropped more than 10%, $ZAI LAB(09688)$ declined over 8%, $BEONE MEDICINES(06160)$, $INNOCARE(09969)$ and $REMEGEN(09995)$ each fell more than 3%, and $SKB BIO(06990)$ slid over 2%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995","09926","09688","06160","09969","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189523975","title":"RemeGen Repurchases 60,000 Shares Through September","url":"https://stock-news.laohu8.com/highlight/detail?id=1189523975","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189523975?lang=en_us&edition=fundamental","pubTime":"2026-10-08 17:28","pubTimestamp":1791451702,"startTime":"0","endTime":"0","summary":"RemeGen (09995) announced that, as of September 30, 2026, the company had cumulatively repurchased 60,000 of its own shares through the centralized bidding trading method via the Shanghai Stock...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","LU2148510915.USD","LU2328871848.SGD","LU1064130708.USD","09995","BK0239","BK1583","LU1064131003.USD","LU2488822045.USD","BK1161","688331","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123881959","title":"RemeGen Maintains Stable Share Base in September; Executes RMB2.16 Million A-Share Buyback for Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1123881959","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123881959?lang=en_us&edition=fundamental","pubTime":"2026-10-06 16:44","pubTimestamp":1791276251,"startTime":"0","endTime":"0","summary":"RemeGen Co., Ltd. (RemeGen) has filed its Monthly Return for Equity Issuer for the period ended 30 September 2026 with Hong Kong Exchanges and Clearing Limited, confirming minimal changes to its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715686","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715686","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715686?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:50","pubTimestamp":1790934645,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsOct 2 (Reuters)-Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Swiss drugmaker NovartisNOVN.Sto develop an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0545039389.USD","LU0106261372.USD","ELIL","09995","BK4592","IE00B5MMRT66.SGD","LU0354030438.USD","LU2602419157.SGD","LU0289961442.SGD","IE00B3PB1722.GBP","WDNA","LU0792757196.USD","LU1162221912.USD","BK5011","LU0353189680.USD","LU0006306889.USD","LU1989771016.USD","LU2491049909.HKD","THNR","600276","LU0130102774.USD","LU0661504455.SGD","LU1019632923.USD","LU1929549753.HKD","LU2539964713.USD","LU1974910355.USD","LU1093756325.SGD","SG9999014914.USD","LU0920783379.SGD","LU2211815571.USD","688331","IE00BGHQF631.EUR","SG9999002232.USD","IE00BVYPNV92.GBP","RXL","LU0348735423.USD","LU0321505439.SGD","IE0002270589.USD","LU1267930730.SGD","LU0348784397.USD","IE00B7KXQ091.USD","LU0971552673.USD","IE00BKDWB100.SGD","LU2476274308.USD","BMY","IE00B3M56506.USD","LU0225283273.USD","KURE","LU2265009873.SGD","IE000BZT7R73.USD","XLV","LU2399975544.HKD","LU1732800096.USD","LU0210536198.USD","LU2091194634.USD","LU0211327993.USD","AZN.UK","LU2746668461.USD","LU0477156953.USD","IE0005OL40V9.USD","LU0857590862.USD","LU2750360997.AUD","LU2087625088.SGD","LU1309081286.SGD","NVO","LU2471134879.HKD","BK0028","00013","LU1037948541.HKD","LU0980610538.SGD","LU1880407132.USD","LU0326950275.SGD","IE00BK4W5L77.USD","03165","LU1997245094.SGD","LU0158827781.USD","LU1571399168.USD","LU2361044865.SGD","NVOC","LU1267930490.SGD","LU2580892789.USD","LU0011850046.USD","LU0289739343.SGD","IE00B19Z3B42.SGD","BK1515","LU0784385840.USD","IE00BKVL7J92.USD","LU1170363599.USD","BK4581","LU0795875169.SGD","LU2168564495.EUR","BK4534","LU1066051498.USD","LU2462591350.SGD","LU2111349929.HKD","LU0067412154.USD","LU1580142542.USD","LU1366192091.USD","LU1328615791.USD","LU0154236417.USD","SG9999014880.SGD","LU0158827948.USD","688506","LU0096364046.USD","LU0170899867.USD","LU1670711040.USD","LU0405327494.USD","RHHBY","LU0823416689.USD","IE00BN8TJ469.HKD","LU2778985437.USD","IE0034235188.USD","LU1814569148.SGD","LU0672654240.SGD","LU0976567544.SGD","LU0738911758.USD","SG9999004220.SGD","LU0203347892.USD","LU1400636491.USD","BK1521","LU2097828714.EUR","LU1355424745.HKD","LU0070302665.USD","GB00BDT5M118.USD","LU1301847155.USD","LU0405327148.USD","LU0417517546.SGD","IE00B1XK9C88.USD","IE0008369823.USD","BK1587","IE00B4R5TH58.HKD","IE00B19Z3581.USD","OZEM","IE00BZ1G4Q59.USD","LU1670756490.USD","IE00BQJZX424.USD","BK4007","LU0987226296.USD","LU0784383803.USD","LU1794554557.SGD","LU2114397693.USD","BK1191","LU2023250504.SGD","LU1061106388.HKD","LU0203201768.USD","LU1323610961.USD","LU0466842654.USD","IBBQ","LU2750360641.GBP","03933","LU0957799991.USD","IE000WAW04H5.SGD","LU1934455863.HKD","IE00BJT1NW94.SGD","LU0225771236.USD","LU0238689110.USD","02096","IBB","LU0463099449.HKD","LU1894683348.USD","LU2488822045.USD","HCM","LU2129689605.HKD","HK0000165453.HKD","LU1863844749.USD","LU0820562030.AUD","LU0320765059.SGD","LU0124676726.USD","LU0161305163.EUR","LU0965509283.SGD","BK0183","LU1066051811.HKD","LU0787776722.HKD","LU2168564149.EUR","LU0320765489.SGD","LU1623119135.USD","LU1917777945.USD","LU0133085943.USD","LU1880407215.USD","LU2242646821.SGD","LU0985481810.HKD","LU1923622614.USD","SGXZ81514606.USD","LU1993786604.SGD","LU1236620834.HKD","LU1670710661.SGD","LU0203202063.USD","LU1960683339.HKD","IE0002141913.USD","LU0256863811.USD","LU0072461881.USD","LU1035773651.USD","LU0345770308.USD","LU0211326839.USD","LU0997586432.USD","LU1064130708.USD","LU0949170426.SGD","LU0306807586.USD","LU0964806797.USD","LU0943347566.SGD","LU2063271972.USD","LU0575583348.USD","LU2168563687.JPY","LU0861579265.USD","LU1202635105.USD","LU1051770623.HKD","LU2756315664.SGD","IE00B42XCP33.USD","IE00B543WZ88.USD","LU0047473722.SGD","LU0972486137.USD","LU2433249047.HKD","PAWZ","MHIP","LU0316494557.USD","LU2746668974.SGD","SG9999003800.SGD","TBXU","LU0634319403.HKD","LU0640476718.USD","IE00BJLML261.HKD","LU2347655156.SGD","LU0057025933.USD","BK4566","LU0244354667.USD","LU1119994496.HKD","LU1228905037.USD","NVS","BK1593","LU2039709279.SGD","SG9999015952.SGD","LU1820825898.SGD","LU0889565080.SGD","LU1934455277.USD","LU2461242641.AUD","LU0795875086.SGD","LLYX","LU1868837136.USD","IE00BKPKM429.USD","BBH","LU0310799852.SGD","LU0472753341.HKD","LU0471298694.HKD","LU1813983027.USD","LU1829250122.USD","LU0887340254.USD","LU0920840948.USD","LU1280957306.USD","LU0456855351.SGD","IYH","LU0047473722.EUR","IE00B1BXHZ80.USD","LU1145028129.USD","IE00BZ08YT58.USD","LU0058720904.USD","GSK.UK","BMED","LU2242644610.SGD","JDOC","IE00BVYPNW00.USD","IE00BJJMRY28.SGD","LU0880133367.SGD","SG9999013999.USD","LU0314109678.HKD","LU2089283258.USD","LU0130517989.USD","LU0960981461.USD","LU2491050071.SGD","LU2237443382.USD","LU2293690082.USD","LU0211331839.USD","IE000M9KFDE8.USD","LU0786609619.USD","LU0128525689.USD","LU0827474353.SGD","SGXZ51526630.SGD","LU1487256676.USD","BK4585","LU0052756011.USD","LU2237443978.SGD","LU2462157665.USD","LU2360106947.USD","LU2552382215.SGD","LU0499090636.EUR","SG9999015978.USD","LU0072913022.USD","LU0289739699.SGD","TRUH","LU1244550221.USD","LU2237443895.HKD","LU2133065610.SGD","LU2357627491.SGD","LU2097828631.EUR","LU2237443622.USD","CANC","LU0784384876.USD","LU1655091616.SGD","LU1988902786.USD","IE00BLSP4452.SGD","LU2279689827.SGD","SG9999014575.USD","LU1273509221.SGD","LU2360032135.SGD","BNTX","LU2168564222.USD","LU1496350502.SGD","IXJ","LU0162691827.USD","LU1188198961.HKD","LU0432979614.USD","LU2125909593.SGD","LU0211326755.USD","LU1645745479.HKD","SG9999014567.USD","LU1066051225.USD","LU2552382058.USD","LU0171293334.USD","LU1069344957.HKD","LU1244550494.USD","LU1670711123.USD","BK4588","LU2468319806.SGD","01093","LU0502904849.HKD","LU2023250843.SGD","LU0501845795.SGD","IE00BWXC8680.SGD","LU2023251221.USD","LU2108987350.USD","LU0823399737.USD","LU0882574139.USD","LU0561508036.HKD","LU2361045086.USD","BK0196","LU2125909247.SGD","IE00BZ08YR35.GBP","BK0188","BK1161","LU0963555726.SGD","LU2237443549.SGD","LU0198837287.USD","SGXZ31699556.SGD","LU0965509101.SGD","LU0640478417.SGD","LU1400636574.HKD","SGXZ57979304.SGD","BK4550","LU2552382132.HKD","LU1831875114.USD","IE00BKPKM643.USD","LU0109981661.USD","LU2289578879.USD","IE00B031HY20.USD","LU1008478684.HKD","LU1548497426.USD","LU2362541273.HKD","LU2097828474.EUR","LU1551013425.SGD","LU2596442595.SGD","IE00BN29S564.USD","IE00BFSS7M15.SGD","LU2097828557.USD","IE00B3T34201.USD","LU0708995401.HKD","SG9999017495.SGD","LU1093756168.USD","LU1146622755.USD","SMMT","LU1983299246.USD","LU2347655073.USD","ELIS","LU0353189763.USD","LU0971552830.HKD","LU0097036916.USD","LU0390134368.USD","BK4516","LU2357305700.SGD","IE00BJJMRZ35.SGD","LU0496365809.HKD","GDOC","LU0256863902.USD","SG9999014898.SGD","IE00B4JS1V06.HKD","LU0310800379.SGD","LU1255011170.USD","LU1934455194.USD","BK1583","LU1781817850.SGD","LU1226288253.USD","LU0237698245.USD","LU1127390331.HKD","BK4535","LU0912757837.SGD","LU1883839398.USD","IE0009355771.USD","LU0820561909.HKD","LU0211328371.USD","LU1670627923.USD","LU2087621335.USD","HRTS","SG9999018865.SGD","LU3187612489.SGD","09926","IE00BSNM7G36.USD","LU1670710588.SGD","LU0265550359.USD","LU2125154778.USD","VHT","LU1551013342.USD","LU1069347547.HKD","LU1691799644.USD","LU1969619763.USD","LU1302929846.USD","LU0267386448.USD","LU0345770993.USD","LU0683600562.USD","SG9999014906.USD","LU2456880835.USD","SG9999001176.SGD","LU1153585028.USD","LU0540923850.HKD","LU1152091754.HKD","LU2355687059.USD","LU0726765562.USD","LU0174119429.USD","LU1064927863.SGD","NVOH","LU2361044949.HKD","IE0008368742.USD","LU1152091168.USD","LU0417516571.SGD","LU1430594728.SGD","LU1951186391.HKD","IE00BZ08YS42.EUR","LU2896262040.SGD","LU0265550946.USD","SG9999014542.SGD","LU1046248800.SGD","LU2271345857.HKD","LU0648001328.SGD","ILDR","BK4533","LU0109394709.USD","LU0823434583.USD","IE00B775H168.HKD","IE0004445015.USD","LU1291159041.SGD","LU1894683264.USD","LU1807302812.USD","LU0455707207.USD","TMED","LU2129689514.USD","LU2471134523.USD","LLYZ","LU2646069778.SGD","LU1267930227.SGD","LU1064131342.USD","BK1589","LU1585245621.USD","LU1023059063.AUD","LU2236285917.USD","LU1481599808.USD","IE0000B7K699.USD","LU1228905540.USD","LU0310800965.SGD","IHE","SG9999015341.SGD","BK0060","LU0122379950.USD","LU1244550577.SGD","IE0004445239.USD","BK1588","LU1979441026.SGD","LU1074936037.SGD","LU2089284900.SGD","LU2362541513.USD","LU1718418525.SGD","AGNG","IE0001KFT4U8.USD","LU1003077747.HKD","REGN","BK4568","LU1046234339.USD","LU1961090484.USD","LU0321505868.SGD","LU0607220059.USD","LU2097828805.USD","IE00BFTCPJ56.SGD","LU1868837300.USD","LU1201861249.SGD","GLAM","LU2028103732.USD","LU2129689431.USD","BK4532","IE000SO60NU8.SGD","LLY","LU1057294990.SGD","LU0069063385.USD","LU1098665638.USD","IE00BJJMRX11.SGD","LU0171276677.USD","LU0140636845.USD","LU1989772923.USD","MRK","LU2089984988.USD","LU0079474960.USD","LU1226288170.HKD","LU1629891620.HKD","LU0348825331.USD","LU0345777147.USD","LU1037948897.HKD","LU1226287792.SGD","LU0348766576.USD","LU2213496289.HKD","SG9999001176.USD","PFE","LU1196032939.SGD","LU2476274720.SGD","LU2148510915.USD","LU2756315318.SGD","LU0708994859.HKD","LU2023250330.USD","LU0868494617.USD","BK4548","SG9999014559.SGD","LU2491050154.USD","LU1699723380.USD","LU1868836914.USD","IE00BDGV0183.EUR","LU0234570918.USD","LU1261432733.SGD","SGXZ99366536.SGD","03692","IE00BWDBJ516.SGD","LU0029864427.USD","LU0985320562.USD","LU1226287875.USD","LU0545562505.USD","LU0511384066.AUD","LU0949170772.SGD","SG9999015358.SGD","LU2106854487.HKD","LU0320765992.SGD","LU0315179316.USD","SG9999015986.USD","BK4139","LU2168564065.EUR","LU0820561818.USD","FHLC","IE00B2B36J28.USD","IE00BK4W5M84.HKD","LU1481600234.SGD","LU2328871848.SGD","LU2495084118.USD","LU0889565916.HKD","LU2471134952.CNY","LU0889566641.SGD","BK4551","LU0323591593.USD","LU0965509010.AUD","LU1720051108.HKD","LU0526926950.USD","LU1035777561.USD","LU0964807845.USD","LU0149534421.HKD","LU0094547139.USD","LU0203345920.USD","ABBV","LU1941712264.USD","LU1032466523.USD","IE00BFXG1179.USD","LU0128525929.USD","BK4578","LU0348767384.USD","SG9999001440.SGD","LU0077335932.USD","MEDI","LU1015430645.USD","LU2362540622.SGD","LU0417516902.SGD","IE000MB6IJN5.SGD","LU1496350171.SGD","LU0868494708.USD","LU1236620750.USD","LU0757432116.USD","LU0109391861.USD","LU1226287529.USD","LU0348783233.USD","NVOX","PPH","LU1863844665.USD","LU0553294199.USD","IE00BBT3K403.USD","BK0239","LU1941712348.USD","LU0345777659.USD","LU0965508806.USD","LU0997586515.USD","LU0053666078.USD","LU2580892862.HKD","LU0320765646.SGD","LU1064131003.USD","LU1153584641.USD","BK1574","LU0689472784.USD","LU0061475181.USD","LU1670628061.USD","MEDX","LU1104425308.USD","LU1989772840.SGD","LU2324357040.USD","LU1116320901.HKD","BK0012","BK4559","IE0034235071.USD","LU1035775433.USD","LU0234572021.USD","LU1804176565.USD","LU0385154629.USD","01801","LU2471134796.USD","LU2417539215.USD","LU1084165304.USD","LU2237443465.HKD","LU1839511570.USD","LU1868836757.USD","LU1997244956.HKD","LU0859254822.USD","LU1868836591.USD","LU1066053197.SGD","BK4599","IE00BFSS8Q28.SGD","FTXH","LU1078025761.USD","LU1720051017.SGD","SG9999011175.SGD","CURE","LU0208291251.USD","LU0882574055.USD","LU0395794307.EUR","LU1997245177.USD","LU0969580561.USD","LU1267930573.SGD","IE00BPRC5H50.USD","LU0417516738.SGD","LU1328277881.USD","LU2293690249.USD","01530","LU0306806265.USD","LU0348827113.USD","IE00BLSP4239.USD","LU0557290698.USD","LU2242652126.USD","LU0689626769.HKD","SG9999018857.SGD","LU0471298777.SGD","LU2237438978.USD","SG9999002224.SGD","LU1003076772.USD","IE000F7OJYX1.SGD","PJP","LU2264538146.SGD","LU1712237335.SGD","LU0114720955.EUR","LU0098860793.USD","LU2112291526.USD","LU1732799900.SGD","LU0225284248.USD","LU1400636657.SGD","LU0942090050.USD","LU0266013472.USD","LU0354030511.USD","LU1232071149.USD","SG9999015945.SGD","LLII","LU1116320737.USD","LU0823434740.USD","LU1019634622.SGD","LU0784385170.HKD","LU1267930813.SGD","01276","LU2125154935.USD","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166541763","title":"Hong Kong Stock Movers: Innovative Drug Stocks Retreat, InnoCare Pharma (09969) Falls Over 8%, RemeGen (09995) Drops Nearly 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166541763","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166541763?lang=en_us&edition=fundamental","pubTime":"2026-10-02 15:52","pubTimestamp":1790927535,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks broadly retreated, with InnoCare Pharma (09969) falling 8.38% to HK$13.55, RemeGen (09995) dropping 5.71% to HK$72.7, and 3SBio (01530) declining 4.95% to HK$15.75 as...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","BK1574","BK1593","LNGR","LU1064130708.USD","KCAI","09969","MEDX","LU2148510915.USD","01530","688428","IBBQ","BK1583","BK4588","BK0239","LU1064131003.USD","688331","VXUS","LU2328871848.SGD","09995","BK1161","HK0000165453.HKD","LU2488822045.USD","159992","06978","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172648555","title":"Movement Alert｜REMEGEN Falls 7.65% in Regular Trading, Trading at 71.45 HKD","url":"https://stock-news.laohu8.com/highlight/detail?id=1172648555","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172648555?lang=en_us&edition=fundamental","pubTime":"2026-10-02 09:53","pubTimestamp":1790906011,"startTime":"0","endTime":"0","summary":"On October 2, REMEGEN fell 7.65% in regular trading, trading at 71.45 HKD/share, with turnover of 27.75 million HKD.Within the Biotechnology sector where REMEGEN belongs, the overall sector was...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672475774","title":"Does Long Term Trial Data Change The Bull Case For RemeGen Stock (SEHK:9995)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672475774","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672475774?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:12","pubTimestamp":1790849562,"startTime":"0","endTime":"0","summary":"Vor Bio reported a post hoc analysis of RemeGen partner trial data in adults with generalized myasthenia gravis, showing that telitacicept produced deep, durable minimal symptom expression over 48 weeks with no new safety signals in a 114-patient Phase 3 study in China.\nThe analysis suggests telitacicept could matter commercially for RemeGen, with around 42% of treated participants achieving minimal symptom expression and many sustaining it over time, including those who started with higher...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/does-long-term-trial-data-change-the-bull-case-for-remegen-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/does-long-term-trial-data-change-the-bull-case-for-remegen-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1574","LU1969619763.USD","LU2328871848.SGD","BK1583","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142205216","title":"RemeGen Biotech Shares Rise Over 3% in Late Trading; Telitacicept gMG China Phase III Analysis Results Presented at AANEM Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1142205216","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142205216?lang=en_us&edition=fundamental","pubTime":"2026-09-30 15:54","pubTimestamp":1790754863,"startTime":"0","endTime":"0","summary":"RemeGen Biotech (09995) shares rose more than 3% in late trading, up 3.01% to HK$77.05 as of press time, with a turnover of HK$219 million.On the news front, according to RemeGen Biotech's official...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","VXUS","KCAI","LU2488822045.USD","688331","09995","BK4588","BK1161","BK1574","LU2148510915.USD","BK0239","LU2328871848.SGD","LU1064131003.USD","BK4585","BK1583","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145734640","title":"Movement Alert｜REMEGEN Rises 5.13% in Regular Trading, Biotech Sector Rally Extends Amid Innovative Drug Boom","url":"https://stock-news.laohu8.com/highlight/detail?id=1145734640","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145734640?lang=en_us&edition=fundamental","pubTime":"2026-09-29 10:47","pubTimestamp":1790650025,"startTime":"0","endTime":"0","summary":"On September 29, REMEGEN rose 5.13% in regular trading, trading at 74.85 HKD/share, with turnover of 149 million HKD. The move came as the broader biotech sector continued its rally, with AKESO...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"REMEGEN Surges on AbbVie Deal as CLSA Lifts Target to 144.8","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131926731","title":"Movement Alert｜REMEGEN Falls 5.08% in Regular Trading, Biotech Sector Under Pressure Amid Earnings Sustainability Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1131926731","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131926731?lang=en_us&edition=fundamental","pubTime":"2026-09-24 09:37","pubTimestamp":1790213835,"startTime":"0","endTime":"0","summary":"On September 24, REMEGEN fell 5.08% in regular trading, trading at 75.5 HKD/share, with turnover of approximately 35.35 million HKD. The decline came as the broader biotechnology sector weakened and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"REMEGEN Slumps as AbbVie Deal Profit Sustainability Questioned","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169418838","title":"RemeGen Turns Profitable on Licensing Windfall and Strong Drug Sales; H1 Revenue Jumps to RMB 5.85 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1169418838","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169418838?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:50","pubTimestamp":1790153458,"startTime":"0","endTime":"0","summary":"RemeGen Co., Ltd. reported a sharp turnaround for the first half of 2026, moving from a RMB 449.57 million net loss a year earlier to a RMB 4.66 billion profit as licensing income and rising product...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"RemeGen Turns Profitable on Licensing Windfall and Strong Drug Sales; H1 Revenue Jumps to RMB 5.85 Billion","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125223612","title":"HK Movers | Innovative Drug Stocks Rally Broadly; LEPU BIO, INNOCARE, AKESO Jump Over 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125223612","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125223612?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:59","pubTimestamp":1789955946,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks rose across the board. $LEPU BIO(02157)$, $INNOCARE(09969)$ and $AKESO(09926)$ gained over 7%, while $REMEGEN(09995)$, $EVEREST MED(01952)$, $INNOVENT BIO(01801)$, $GENSCRIPT BIO(01548)$ and $SKB BIO(06990)$ rose over 6%, $3SBIO(01530)$ advanced over 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","09969","01548","01530","02157","01801","09995","09926","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183071595","title":"Movement Alert｜REMEGEN Rises 5.35% in Regular Trading, RC148 Lung Cancer Clinical Data Debut at World Lung Cancer Conference Draws Market Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=1183071595","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183071595?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:42","pubTimestamp":1789954951,"startTime":"0","endTime":"0","summary":"On September 21, REMEGEN rose 5.35% in regular trading, trading at HK$78.75/share, with turnover of HK$71.61 million.On the news front, the PD-1/VEGF bispecific antibody RC148, co-developed by...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"REMEGEN Surges on RC148 Lung Cancer Data; CLSA Ups Target to HK$144.8","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113110252","title":"RemeGen's RC148 Challenges Akeso's Dominance in Lung Cancer Space, Projected to Hit 3.6B Yuan in Peak Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1113110252","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113110252?lang=en_us&edition=fundamental","pubTime":"2026-09-17 14:20","pubTimestamp":1789626032,"startTime":"0","endTime":"0","summary":"The valuation of innovative drug companies is fundamentally anchored to their pipeline value, and for RemeGen, the PD-1/VEGF bispecific antibody RC148—its core asset in the tumor immunotherapy...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","LU1794554557.SGD","LU2476274308.USD","LU0348827113.USD","IE00B543WZ88.USD","09995","BK1583","LU1961090484.USD","KURE","LU2148510915.USD","LU0561508036.HKD","LU0348766576.USD","LU0348784397.USD","LU0540923850.HKD","LU2778985437.USD","LU0417516571.SGD","LU1720050803.USD","IE00B5MMRT66.SGD","BK0239","IE00BPRC5H50.USD","LU1064130708.USD","LU0348783233.USD","LU0417516902.SGD","LU2399975544.HKD","688331","BK1161","09926","LU0634319403.HKD","LU2488822045.USD","LU1969619763.USD","LU2476274720.SGD","LU0417516738.SGD","LU0348767384.USD","BK1574","LU0348825331.USD","LU0348735423.USD","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115866351","title":"HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=1115866351","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115866351?lang=en_us&edition=fundamental","pubTime":"2026-09-11 11:13","pubTimestamp":1789096425,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks are experiencing sustained downward pressure in Hong Kong trading. As of the latest update, LEPU BIO (02157) has declined 3.91% to HK$38.05, while REMEGEN (09995) fell...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE","LU2039709279.SGD","LU1807302812.USD","LU1152091168.USD","LU0455707207.USD","LU0149534421.HKD","LU1960683339.HKD","LU0244354667.USD","LU1226287792.SGD","SG9999004220.SGD","159992","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","LU0067412154.USD","LU0880133367.SGD","LU0607220059.USD","BK1521","LU1831875114.USD","LU0140636845.USD","LU1993786604.SGD","LU2097828474.EUR","LU2097828805.USD","LU1008478684.HKD","LU0463099449.HKD","WRTH","BK1515","BK4585","LU1188198961.HKD","LU2097828714.EUR","BK1574","VXUS","02157","HK0000165453.HKD","BK1583","LU1226287875.USD","LU0072913022.USD","LU1152091754.HKD","01801","BK1161","09995","IE00B543WZ88.USD","LU1226287529.USD","IE00BZ08YS42.EUR","LU2488822045.USD","LNGR","LU0501845795.SGD","LU1951186391.HKD","BK1589","LU0315179316.USD","BK4588","IE00B031HY20.USD","LU0326950275.SGD","BK1191","LU1969619763.USD","LU1226288170.HKD","PEVC","IE00BZ08YR35.GBP","KCAI","LU2242644610.SGD","IE0008368742.USD","IBBQ","LU1226288253.USD","LU1328277881.USD","MCRO","MEDX","LU0502904849.HKD","IE0008369823.USD","LU2328871848.SGD","06978","LU2097828557.USD","LU0314109678.HKD","LU1813983027.USD","LU2097828631.EUR","01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143231072","title":"Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1143231072","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143231072?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:20","pubTimestamp":1788780027,"startTime":"0","endTime":"0","summary":"Remegen Co., Ltd. announced on September 7 that it will join the collective earnings communication session for the innovative drug industry on the STAR Market for the first half of 2026, scheduled...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","LU1064131003.USD","159992","BK1574","MEDX","IBBQ","LNGR","LU2148510915.USD","LU2328871848.SGD","LU1064130708.USD","BK1161","BK0239","688331","06978","09995","KSTR","BK1583","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188413163","title":"RemeGen Maintains Stable Share Base; Minor A-Share Buyback Adds to Treasury in August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1188413163","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188413163?lang=en_us&edition=fundamental","pubTime":"2026-09-04 17:44","pubTimestamp":1788515048,"startTime":"0","endTime":"0","summary":"Hong Kong-listed biopharmaceutical company RemeGen Co., Ltd. released its Monthly Return on Movements in Securities for August 2026, showing a largely unchanged share structure with a small...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118027728","title":"REMEGEN Discloses Cumulative Buyback of 41,000 A-Shares by End of August","url":"https://stock-news.laohu8.com/highlight/detail?id=1118027728","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118027728?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:04","pubTimestamp":1788350652,"startTime":"0","endTime":"0","summary":"REMEGEN (09995) has released an announcement detailing its share repurchase activities.As of August 31, 2026, the company had repurchased a cumulative total of 41,000 A-shares through the Shanghai...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159982","LU2328871848.SGD","07233","688331","LU1969619763.USD","BK1583","BK1574","03130","LU1064130708.USD","LU1064131003.USD","83188","09995","LU2148510915.USD","82846","BK1161","LU2488822045.USD","BK0239","02846","399300","83130","03188","BK1147","02827"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.073},{"period":"1month","weight":-0.123},{"period":"3month","weight":-0.2159},{"period":"6month","weight":-0.4441},{"period":"1year","weight":-0.2553},{"period":"ytd","weight":-0.0743}],"compareEarnings":[{"period":"1week","weight":0.0076},{"period":"1month","weight":-0.0242},{"period":"3month","weight":-0.0278},{"period":"6month","weight":-0.0706},{"period":"1year","weight":-0.0443},{"period":"ytd","weight":-0.0514}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"RemeGen Co Ltd is a China-based company principally engaged in biopharmaceutical research, biopharmaceutical service, biopharmaceutical production and sale. The Company focuses on therapeutic antibody drugs such as antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company’s main products include telitacicept, disitamab vedotin, RC28-E and others. The Company's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The Company mainly operates its businesses in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.110172},{"month":2,"riseRate":0.666667,"avgChangeRate":0.167223},{"month":3,"riseRate":0.5,"avgChangeRate":0.012545},{"month":4,"riseRate":0.833333,"avgChangeRate":0.095268},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.049233},{"month":6,"riseRate":0.666667,"avgChangeRate":0.089626},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.010221},{"month":8,"riseRate":0.333333,"avgChangeRate":0.055035},{"month":9,"riseRate":0.5,"avgChangeRate":0.07525},{"month":10,"riseRate":0.333333,"avgChangeRate":0.000614},{"month":11,"riseRate":1,"avgChangeRate":0.038747},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.053467}],"exchange":"SEHK","name":"REMEGEN","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest REMEGEN(09995) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"REMEGEN,09995,REMEGEN股票,REMEGEN股票老虎,REMEGEN股票老虎国际,REMEGEN行情,REMEGEN股票行情,REMEGEN股价,REMEGEN股市,REMEGEN股票价格,REMEGEN股票交易,REMEGEN股票购买,REMEGEN股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest REMEGEN(09995) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}